LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
Weiwei Tang(Nanjing University of Chinese Medicine), Suryavathi Viswanadhapalli(The University of Texas at San Antonio Health Science Center)
Cited by 35
Related Papers
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
|Signal Transduction and Targeted Therapy|2020|1.1k